Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

Background/Aim: The primary aim of this study was to assess the efficacy of a bismuth-based quadruple regimen as first-line therapy for Helicobacter pylori (HP) eradication in diabetes mellitus (DM) patients. The secondary aim was to study the effect of HP eradication on dyspeptic symptoms in DM pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestion 2010-01, Vol.82 (1), p.47-53
Hauptverfasser:	Demir, Mehmet, Göktürk, Savaş, Öztürk, Nevin Akçaer, Serin, Ender, Yilmaz, Uğur
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use Amoxicillin - therapeutic use Antacids - therapeutic use Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - therapeutic use Bismuth - therapeutic use Case-Control Studies Chi-Square Distribution Clarithromycin - therapeutic use Diabetes Mellitus, Type 2 - complications Drug Therapy, Combination Female Helicobacter Infections - complications Helicobacter Infections - diagnosis Helicobacter Infections - drug therapy Helicobacter pylori Helicobacter pylori - drug effects Humans Male Metronidazole - therapeutic use Middle Aged Original Paper Proton Pump Inhibitors - therapeutic use Statistics, Nonparametric Surveys and Questionnaires Tetracycline Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!